Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It looks like some one want more cbis at lower price just before 10k out. Is it a smart or greedy strategy?
GW will enter Nasdaq soon as gwph. Cbis need speed up its step!
Two more words: Hold and Buy!
GO CBIS!
Michael McGrath, MD, PhD has a lot of AIDS resource: patients, specimens, funding, FDA application, etc, etc....
Would any famous professor like to exchange his/her reputation with 1 million shares of CBIS? Just curious!
So far, CBIS moves forward in its own steps, even though it is very slow. The best thing is that there is no pump and dump, of course there are lots on this board.
We are looking forward to the first kick on the door of FDA!
Go CBIS
Do more professors increase the chance of FDA application?
What happens to GBEN?
Any news or just pump?
I do not come here for a while, do I miss sth?
I see the target price $1, and I have to make sure that I am on the GBEN borad.
Anyway, GO GBEN!
If the FDA application is submitted and then approved, the 90mil share of 100mil may be the fund for human clinical trial. I believe that most of CBIS holders accept that, and also most holder of Class A in the future would not like to convert into Class B.
GO CBIS!
To be yourself, use our own judgement for cbis.
I believe cbis is working on its project. I do not persuade you hold/buy/sell cbis.
GO CBIS
why not? CBIS still has 100mil class a. I believe CBIS will at least submit one time FDA application. Trust yourself, please do not trust others judgement.
Good News for CBIS!
Just look over the GW patent, a hurry-up one.
It is absolutely good news for CBIS. It mainly discusses prostate cancer. There are four time mentions `Skin`, but there is not any evidence in their application at all. However, CBIS has at least three patients in former PRs. Of course, there is no anything about AIDS/HIV in GW patent application.
GW patent application has no any conflict with CBIS project, but it provides more evidence that mmj can cure cancer.
If CBIS has a smart management team, there will be a following up PR about FDA application shortly. IMO
That is not a synthetic medicine. Any company can submit individual method patent, you may use heat method, they may use alcohol method,and.... The only thing is the effect of curing cancer: who can prove it in human clinical trial.
CBIS can do it soon.
so inkjet printer applied for patent, laser printer cannot apply for patent. Is that your meaning?
cbis can apply for its own patent
although other company submitted patent application, cbis can do it. Some ones on board think cbis can not apply for patent, it is totally wrong. cbis can apply for its own patent.
cbis will submit some thing to NIH very soon, maybe this week or this month
GO CBIS
CBIS, do you make all on your board happy?
When CBIS says mmj oil cure cancer, someone need evidence.
After CBIS provides in vitro results, someone need in vivo.
After CBIS provide in vivo results, someone need human clinical trail.
If there are human clinical results done before, it is not necessary to do it again.
CBIS will apply for the permit from FDA to perform human clinical trials curing cancer.
GO CBIS
tell us the meaning of `when administered to two patients` in the paper. did you read it, or just ignore it?
GO CBIS!
are you serious about your post?
http://mpkb.org/home/patients/assessing_literature/in_vitro_studies
In vitro studies
In vitro (Latin for within the glass) refers to the technique of performing a given procedure in a controlled environment outside of a living organism. Many experiments in cellular biology are conducted outside of organisms or cells. One of the abiding weaknesses of in vitro experiments is that they fail to replicate the precise cellular conditions of an organism, particularly a microbe. To cite one example among many, the lysates or extracts from culture-grown spirochetes do not reflect antigens expressed in the mammalian Borrelia:
In vivo studies
In vivo (Latin for “within the living”) refers to experimentation using a whole,living organism as opposed to a partial or dead organism. Animal studies and clinical trials are two forms of in vivo research. In vivo testing is often employed over in vitro because it is better suited for observing the overall effects of an experiment on a living subject.
While there are many reasons to believe in vivo studies have the potential to offer conclusive insights about the nature of medicine and disease, there is a number of ways that these conclusions can be misleading. For example, a therapy can offer a short-term benefit, but a long-term harm.
relax, not everyone can understand science paper.
GO CBIS
not clear? when administered to two patients.
CBIS will do it in Human!
Doc, since there are tons of evidence in dish and animal, but not trial in human done before, CBIS will appply for the permit from FDA in order to cure cancer in human body.
Cannot you understand that, can you?
CBIS will do it in Human!
Since there are tons of evidence in dish and animal, but not trial in human done before, CBIS will apply for the permit from FDA in order to cure cancer in human body.
GO CBIS!
that is the reason cbis apply for clinical trails in human. If done, it is not necessary to apply for FDA trial.
because no clinical trials on live humans, but there are evidences in petri dishes, so CBIS will perform clinical trials on live humans. We do not know what happen in clinical trials on live humans, but CBIS will do it! That is all!
GO CBIS!
GO CBIS!
GO CBIS!
$1.00!!!!
If done, why does cbis apply for fda application. What wrong with you?
no buying or no selling? anyone post a L2 shot? Thanks!
what are you talking about? You?
rifreede attacks other person first!
bad management from a worse PR team, imo
cbis even did not release a PR on ASA conference.
no selling at this price? All are waiting for sth?
GO CBIS
worst management of cbis and xchc in all mmj stock!
PR resource has been run out. XCHC loses confidence in the market.
Crash?
xchc uses the website and release PRs on phytiva. But its auditor is unlicensed, so all things about phytiva from XCHC are illegal?
back to $0.05 soon. CBIS will withdraw phytiva!
the more crows, the higher cbis
GO CBIS
See you next week:
over $0.1, and then $0.25
You are wrong!
Next week, CBIS will be over $0.1, may touch $0.25 again!
GO CBIS!
You do not have that chancce at all.
It looks like that you want to load at that price, but you do not have any chance, lol!
I am sorry for you!
GO CBIS!
any news from ASA?
On February 21, 2013, the Board of Directors of the Company was notified by it's auditors, S. W. Hatfield, CPA (SWHCPA) of Dallas, Texas that, as a result of the Asset Purchase Agreement with Cannabis Science, Inc., principally including the Joint Venture Operating Agreement with dupetit Natural Products GmbH (a Germany-based company), as reported in a Current Report on Form 8-K filed on or about December 28, 2012, SWHCPA would not stand for reappointment as the Company's auditing firm for the year ended December 31, 2012.
The Company's Board of Directors has accepted the pending resignation of SWHCPA.
SWHCPA would not stand for the year ended December 31, 2012. So XCHC` 8K on the transaction with CBIS was not audited? Is that right? Do not talk about 2010 and 2011, and the problem is the transaction with CBIS. We do not care about its history.
Those transactions completely destroyed CBIS` reputation, but there is not any benefit belong to XCHC if nobody sign its documents.
There is only one bridge between CBIS and XCHC. You know!
If all things go back to the point before the transaction, CBIS will be OK. Otherwise pr*s*n??? IMO
Bad management for both CBIS and XCHC!